Tiny non-coding RNAs in Parkinson's disease: Implications, expectations and hypes

Neurochemistry International

Volumn 59, Issue 6, 2011, Pages 759-769

  Srivastava, Garima ^a   Dixit, Anubhuti ^a   Prakash, Om ^b   Singh, Mahendra Pratap ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Micro RNA; Parkinson's disease; Small interfering RNA; Tiny non coding RNAs

Indexed keywords

ALPHA SYNUCLEIN; LEUCINE RICH REPEAT KINASE 2; MICRORNA; PLASMID DNA; SMALL INTERFERING RNA; TYROSINE 3 MONOOXYGENASE;

APOPTOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG TARGETING; GENE; GENE FUNCTION; GENE MUTATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; MOLECULAR EVOLUTION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA INTERFERENCE;

EID: 80053171864     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.07.009     Document Type: Short Survey

References (146)

1. Y. Akaneya, B. Jiang, and T. Tsumoto RNAi-induced gene silencing by local electroporation in targeting brain region J. Neurophysiol. 93 2005 594 602 (Pubitemid 40626864)
2. L. Alberi, P. Sgado, and H.H. Simon Engrailed genes are cell-autonomously required to prevent apoptosis in the mesencephalic dopaminergic neurons Development 131 2004 3229 3236 (Pubitemid 39077445)
3. J. Alegre-Abarrategui, H. Christian, M.M. Lufino, R. Mutihac, L.L. Venda, O. Ansorge, and R. Wade-Martins LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model Hum. Mol. Genet. 18 2009 4022 4034
4. S. Asikainen, M. Rudgalvyte, L. Heikkinen, K. Louhiranta, M. Lakso, G. Wong, and R. Nass Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models J. Mol. Neurosci. 41 2010 210 218
5. N.S. Asli, M.E. Pitulescu, and M. Kessel MicroRNAs in organogenesis and disease Curr. Mol. Med. 8 2008 698 710
6. R. Barker Substance P and Parkinson's disease: a causal relationship? J. Theor. Biol. 120 1986 353 362 (Pubitemid 16099218)
7. M. Bauer, N. Kinkl, A. Meixner, E. Kremmer, M. Riemenschneider, H. Forstl, T. Gasser, and M. Ueffing Prevention of interferon-stimulated gene expression using microRNA-designed hairpins Gene Ther. 16 2009 142 147
8. H. Bayir, A.A. Kapralov, J. Jiang, Z. Huang, Y.Y. Tyurina, V.A. Tyurin, Q. Zhao, N.A. Belikova, I.I. Vlasova, A. Maeda, J. Zhu, H.M. Na, P.G. Mastroberardino, L.J. Sparvero, A.A. Amoscato, C.T. Chu, J.T. Greenamyre, and V.E. Kagan Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease J. Biol. Chem. 284 2009 15951 15969
9. E. Bernstein, A.A. Caudy, S.M. Hammond, and G.J. Hannon Role for a bidentate ribonuclease in the initiation step of RNA interference Nature 409 2001 363 366 (Pubitemid 32151243)
10. A. Birmingham, E.M. Anderson, A. Reynolds, D. Ilsley-Tyree, D. Leake, Y. Fedorov, S. Baskerville, E. Maksimova, K. Robinson, J. Karpilow, W.S. Marshall, and A. Khvorova 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets Nat. Methods 3 2006 199 204
11. S.C. Biswas, E. Ryu, C. Park, C. Malagelada, and L.A. Greene Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease Neurochem. Res. 30 2005 839 845 (Pubitemid 41413940)
12. J.P. Blumenstiel, and D.L. Hartl Evidence for maternally transmitted small interfering RNA in the repression of transposition in Drosophila virilis Proc. Natl. Acad. Sci. USA 102 2005 15965 15970 (Pubitemid 41552851)
13. D.A. Braasch, Z. Paroo, A. Constantinescu, G. Ren, O.K. Oz, R.P. Mason, and D.R. Corey Biodistribution of phosphodiester and phosphorothioate siRNA Bioorg. Med. Chem. Lett. 14 2004 1139 1143 (Pubitemid 38229843)
14. C. Burger, O.S. Gorbatyuk, M.J. Velardo, C.S. Peden, P. Williams, S. Zolotukhin, P.J. Reier, R.J. Mandel, and N. Muzyczka Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system Mol. Ther. 10 2004 302 317 (Pubitemid 39117875)
15. J. Cai, A. Donaldson, M. Yang, M.S. German, G. Enikolopov, and L. Iacovitti The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model Stem Cells 27 2009 220 229
16. R.W. Carthew, and E.J. Sontheimer Origins and mechanisms of miRNAs and siRNAs Cell 136 2009 642 655
17. D. Castanotto, and J.J. Rossi The promises and pitfalls of RNA-interference-based therapeutics Nature 457 2009 426 433
18. C.T. Chu, J. Zhu, and R. Dagda Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death Autophagy 3 2007 663 666 (Pubitemid 350060074)
19. M.R. Cookson The biochemistry of Parkinson's disease Annu. Rev. Biochem. 74 2005 29 52 (Pubitemid 40995500)
20. J. Dostie, Z. Mourelatos, M. Yang, A. Sharma, and G. Dreyfuss Numerous microRNPs in neuronal cells containing novel microRNAs RNA 9 2003 180 186 (Pubitemid 36206286)
21. E. Doxakis Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153 J. Biol. Chem. 285 2010 12726 12734
22. T. Du, and P.D. Zamore MicroPrimer: the biogenesis and function of microRNA Development 132 2005 4645 4652 (Pubitemid 41685275)
23. Y. Du, D. Yang, L. Li, G. Luo, T. Li, X. Fan, Q. Wang, X. Zhang, Y. Wang, and W. Le An insight into the mechanistic role of p53-mediated autophagy induction in response to proteasomal inhibition-induced neurotoxicity Autophagy 5 2009 663 675
24. M. Faller, and F. Guo MicroRNA biogenesis: there's more than one way to skin a cat Biochim. Biophys. Acta 1779 2008 663 667
25. O. Garnier, V. Serrano, S. Duharcourt, and E. Meyer RNA-mediated programming of developmental genome rearrangements in Paramecium tetraurelia Mol. Cell. Biol. 24 2004 7370 7379 (Pubitemid 39121467)
26. T. Gasser Genomic and proteomic biomarkers for Parkinson disease Neurology 72 2009 S27 S31
27. S. Gehrke, Y. Imai, N. Sokol, and B. Lu Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression Nature 466 2010 637 641
28. S. Geisler, K.M. Holmstrom, D. Skujat, F.C. Fiesel, O.C. Rothfuss, P.J. Kahle, and W. Springer PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 Nat. Cell Biol. 12 2010 119 131
29. F. Gillardon, M. Mack, W. Rist, C. Schnack, M. Lenter, T. Hildebrandt, and B. Hengerer MicroRNA and proteome expression profiling in early-symptomatic α-synuclein(A30P)-transgenic mice Proteomics Clin. Appl. 2 2008 697 705 (Pubitemid 351772025)
30. S.J. Greco, and P. Rameshwar MicroRNAs regulate synthesis of the neurotransmitter substance P in human mesenchymal stem cell-derived neuronal cells Proc. Natl. Acad. Sci. USA 104 2007 15484 15489 (Pubitemid 47502943)
31. R.I. Gregory, T.P. Chendrimada, N. Cooch, and R. Shiekhattar Human RISC couples microRNA biogenesis and posttranscriptional gene silencing Cell 123 2005 631 640 (Pubitemid 41608466)
32. K. Habig, M. Walter, S. Poths, O. Riess, and M. Bonin RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player Neurogenetics 9 2008 83 94
33. A.H. Hall, J. Wan, A. Spesock, Z. Sergueeva, B.R. Shaw, and K.A. Alexander High potency silencing by single-stranded boranophosphate siRNA Nucleic Acids Res. 34 2006 2773 2781 (Pubitemid 43985638)
34. S. Hamamichi, R.N. Rivas, A.L. Knight, S. Cao, K.A. Caldwell, and G.A. Caldwell Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model Proc. Natl. Acad. Sci. USA 105 2008 728 733 (Pubitemid 351171776)
35. J. Han, Y. Lee, K.H. Yeom, Y.K. Kim, H. Jin, and V.N. Kim The Drosha-DGCR8 complex in primary microRNA processing Genes Dev. 18 2004 3016 3027 (Pubitemid 39658171)
36. J. Han, D. Kim, and K.V. Morris Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells Proc. Natl. Acad. Sci. USA 104 2007 12422 12427 (Pubitemid 47206153)
37. T. Hatano, S. Kubo, S. Imai, M. Maeda, K. Ishikawa, Y. Mizuno, and N. Hattori Leucine-rich repeat kinase 2 associates with lipid rafts Hum. Mol. Genet. 16 2007 678 690 (Pubitemid 46585667)
38. P.G. Hawkins, S. Santoso, C. Adams, V. Anest, and K.V. Morris Promoter targeted small RNAs induce long-term transcriptional gene silencing in human cells Nucleic Acids Res. 37 2009 2984 2995
39. S.S. Hebert, and B. De Strooper Alterations of the microRNA network cause neurodegenerative disease Trends Neurosci. 32 2009 199 206
40. V. Hornung, M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, S. Endres, and G. Hartmann Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7 Nat. Med. 11 2005 263 270 (Pubitemid 40460553)
41. C.H. Hsu, D. Chan, E. Greggio, S. Saha, M.D. Guillily, A. Ferree, K. Raghavan, G.C. Shen, L. Segal, H. Ryu, M.R. Cookson, and B. Wolozin MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2 J. Neurochem. 112 2010 1593 1604
42. C. Isidoro, F. Biagioni, F.S. Giorgi, F. Fulceri, A. Paparelli, and F. Fornai The role of autophagy on the survival of dopamine neurons Curr. Top. Med. Chem. 9 2009 869 879
43. M. Jaber, B. Dumartin, C. Sagné, J.W. Haycock, C. Roubert, B. Giros, B. Bloch, and M.G. Caron Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter Eur. J. Neurosci. 11 1999 3499 34511
44. A.L. Jackson, and P.S. Linsley Noise amidst the silence: off-target effects of siRNAs? Trends Genet. 20 2004 521 524 (Pubitemid 39314555)
45. E. Junn, K.W. Lee, B.S. Jeong, T.W. Chan, J.Y. Im, and M.M. Mouradian Repression of alpha-synuclein expression and toxicity by microRNA-7 Proc. Natl. Acad. Sci. USA 106 2009 13052 13057
46. A. Khvorova, A. Reynolds, and S.D. Jayasena Functional siRNAs and miRNAs exhibit strand bias Cell 115 2003 209 216 (Pubitemid 37329584)
47. D.H. Kim, and J.J. Rossi Strategies for silencing human disease using RNA interference Nat. Rev. Genet. 8 2007 173 184
48. D.H. Kim, L.M. Villeneuve, K.V. Morris, and J.J. Rossi Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells Nat. Struct. Mol. Biol. 13 2006 793 797 (Pubitemid 44338773)
49. E.J. Kim, J.Y. Sung, H.J. Lee, H. Rhim, M. Hasegawa, T. Iwatsubo, S. Min do, J. Kim, S.R. Paik, and K.C. Chung Dyrk1A phosphorylates alpha-synuclein and enhances intracellular inclusion formation J. Biol. Chem. 281 2006 33250 33257 (Pubitemid 46036707)
50. J. Kim, K. Inoue, J. Ishii, W.B. Vanti, S.V. Voronov, E. Murchison, G. Hannon, and A. Abeliovich A MicroRNA feedback circuit in midbrain dopamine neurons Science 317 2007 1220 1224
51. D.H. Kim, P. Saetrom, O. Snove Jr., and J.J. Rossi MicroRNA-directed transcriptional gene silencing in mammalian cells Proc. Natl. Acad. Sci. USA 105 2008 16230 16235
52. S.J. Kish, K. Shannak, and O. Hornykiewicz Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications N. Engl. J. Med. 318 1988 876 880 (Pubitemid 18090271)
53. T. Klockgether Parkinson's disease: clinical aspects Cell Tissue Res. 318 2004 115 120 (Pubitemid 39362632)
54. H.S. Ko, R. Bailey, W.W. Smith, Z. Liu, J.H. Shin, Y.I. Lee, Y.J. Zhang, H. Jiang, C.A. Ross, D.J. Moore, C. Patterson, L. Petrucelli, T.M. Dawson, and V.L. Dawson CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity Proc. Natl. Acad. Sci. USA 106 2009 2897 2902
55. H.S. Ko, Y. Lee, J.H. Shin, S.S. Karuppagounder, B.S. Gadad, A.J. Koleske, O. Pletnikova, J.C. Troncoso, V.L. Dawson, and T.M. Dawson Phosphorylation by the c-Abl protein tyrosine kinase inhibits Parkin's ubiquitination and protective function Proc. Natl. Acad. Sci. USA 107 2010 16691 16696
56. J. Kocerha, M.A. Faghihi, M.A. Lopez-Toledano, J. Huang, A.J. Ramsey, M.G. Caron, N. Sales, D. Willoughby, J. Elmen, H.F. Hansen, H. Orum, S. Kauppinen, P.J. Kenny, and C. Wahlestedt MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction Proc. Natl. Acad. Sci. USA 106 2009 3507 3512
57. S. Krantic, N. Mechawar, S. Reix, and R. Quirion Apoptosis-inducing factor: a matter of neuron life and death Prog. Neurobiol. 81 2007 179 196 (Pubitemid 46282274)
58. T. Kuwahara, A. Koyama, S. Koyama, S. Yoshina, C.H. Ren, T. Kato, S. Mitani, and T. Iwatsubo A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in alpha-synuclein transgenic C. elegans Hum. Mol. Genet. 17 2008 2997 3009
59. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980 (Pubitemid 13189531)
60. C. Lavedan, A. Dehejia, B. Pike, A. Dutra, E. Leroy, S.E. Ide, H. Root, J. Rubenstein, R.L. Boyer, S. Chandrasekharappa, I. Makalowska, R.L. Nussbaum, and M.H. Polymeropoulos Contig map of the Parkinson's disease region on 4q21-q23 DNA Res. 5 1998 19 23 (Pubitemid 128670196)
61. M.T. Le, C. Teh, N. Shyh-Chang, H. Xie, B. Zhou, V. Korzh, H.F. Lodish, and B. Lim MicroRNA-125b is a novel negative regulator of p53 Genes Dev. 23 2009 862 876
62. Y. Lee, M. Kim, J. Han, K.H. Yeom, S. Lee, S.H. Baek, and V.N. Kim MicroRNA genes are transcribed by RNA polymerase II EMBO J. 23 2004 4051 4060 (Pubitemid 39472426)
63. D.W. Lee, D. Kaur, S.J. Chinta, S. Rajagopalan, and J.K. Andersen A disruption in iron-sulfur center biogenesis via inhibition of mitochondrial dithiol glutaredoxin 2 may contribute to mitochondrial cellular iron dysregulation in mammalian glutathione-depleted dopaminergic cells: implications for Parkinson's disease Antioxid. Redox Signal. 11 2009 2083 2094
64. I.S. Lee, J. Lim, J. Gal, J.C. Kang, H.J. Kim, B.Y. Kang, and H.J. Choi Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells Neurochem. Int. 58 2011 153 160
65. L.C. Li, S.T. Okino, H. Zhao, D. Pookot, R.F. Place, S. Urakami, H. Enokida, and R. Dahiya Small dsRNAs induce transcriptional activation in human cells Proc. Natl. Acad. Sci. USA 103 2006 17337 17342 (Pubitemid 44788970)
66. V. Licker, E. Kovari, D.F. Hochstrasser, and P.R. Burkhard Proteomics in human Parkinson's disease research J. Proteomics 73 2009 10 29
67. L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, and J.M. Johnson Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769 773 (Pubitemid 40292988)
68. C. Lipardi, H.J. Baek, Q. Wei, and B.M. Paterson Analysis of short interfering RNA function in RNA interference by using Drosophila embryo extracts and Schneider cells Methods Enzymol. 392 2005 351 371 (Pubitemid 40092525)
69. J. Liu, M.A. Carmell, F.V. Rivas, C.G. Marsden, J.M. Thomson, J.J. Song, S.M. Hammond, L. Joshua-Tor, and G.J. Hannon Argonaute2 is the catalytic engine of mammalian RNAi Science 305 2004 1437 1441 (Pubitemid 39167657)
70. Y. Liu, K. Mochizuki, and M.A. Gorovsky Histone H3 lysine 9 methylation is required for DNA elimination in developing macronuclei in Tetrahymena Proc. Natl. Acad. Sci. USA 101 2004 1679 1684 (Pubitemid 38234214)
71. B. Liu, Q. Shi, S. Ma, N. Feng, J. Li, L. Wang, and X. Wang Striatal 19S Rpt6 deficit is related to alpha-synuclein accumulation in MPTP-treated mice Biochem. Biophys. Res. Commun. 376 2008 277 282
72. D. Liu, L. Jin, H. Wang, H. Zhao, C. Zhao, C. Duan, L. Lu, B. Wu, S. Yu, P. Chan, Y. Li, and H. Yang Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells Neurochem. Res. 33 2008 1401 1409
73. F. Liu, J.L. Nguyen, J.D. Hulleman, L. Li, and J.C. Rochet Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease J. Neurochem. 105 2008 2435 2453 (Pubitemid 351782273)
74. Z. Liu, R.K. Meray, T.N. Grammatopoulos, R.A. Fredenburg, M.R. Cookson, Y. Liu, T. Logan, and P.T. Lansbury Jr. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease Proc. Natl. Acad. Sci. USA 106 2009 4635 4640
75. P. Liu, X. Wang, N. Gao, H. Zhu, X. Dai, Y. Xu, C. Ma, L. Huang, Y. Liu, and C. Qin G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression Brain Res. 1307 2010 134 141
76. B. Lu Recent advances in using Drosophila to model neurodegenerative diseases Apoptosis 14 2009 1008 1020
77. E. Lund, S. Güttinger, A. Calado, J.E. Dahlberg, and U. Kutay Nuclear export of microRNA precursors Science 303 2004 95 98 (Pubitemid 38055779)
78. C. Lundberg, T. Björklund, T. Carlsson, J. Jakobsson, P. Hantraye, N. Déglon, and D. Kirik Applications of lentiviral vectors for biology and gene therapy of neurological disorders Curr. Gene Ther. 8 2008 461 473
79. I.J. MacRae, E. Ma, M. Zhou, C.V. Robinson, and J.A. Doudna In vitro reconstitution of the human RISC-loading complex Proc. Natl. Acad. Sci. USA 105 2008 512 517 (Pubitemid 351171739)
80. E.M. Maine Meiotic silencing in Caenorhabditis elegans Int. Rev. Cell Mol. Biol. 282 2010 91 134
81. F.P. Manfredsson, A.S. Lewin, and R.J. Mandel RNA knockdown as a potential therapeutic strategy in Parkinson's disease Gene Ther. 13 2006 517 524
82. C.D. Marsden, and C.W. Olanow The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality Ann. Neurol. 44 1998 S189 S196
83. O. Mathieu, and J. Bender RNA-directed DNA methylation J. Cell Sci. 117 2004 4881 4888 (Pubitemid 39517505)
84. J.S. Mattick, and I.V. Makunin Non-coding RNA Hum. Mol. Genet. 15 2006 R17 R29
85. P. Maziere, and A.J. Enright Prediction of microRNA targets Drug Discov. Today 12 2007 452 458 (Pubitemid 46795589)
86. A.L. McCormack, S.K. Mak, J.M. Henderson, D. Bumcrot, M.J. Farrer, and D.A. Di Monte Alpha-synuclein suppression by targeted small interfering RNA in the primate substantia nigra PLoS One 5 2010 e12122
87. G.W. Miller, Y.M. Wang, R.R. Gainetdinov, and M.G. Caron Dopamine transporter and vesicular monoamine transporter knockout mice: implications for Parkinson's disease Methods Mol. Med. 62 2001 179 190
88. J. Milosevic, S.C. Schwarz, V. Ogunlade, A.K. Meyer, A. Storch, and J. Schwarz Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation Mol. Neurodegener. 4 2009 25
89. E.P. Murchison, and G.J. Hannon MiRNAs on the move: miRNA biogenesis and the RNAi machinery Curr. Opin. Cell Biol. 16 2004 223 229 (Pubitemid 38610401)
90. P.T. Nelson, W.X. Wang, and B.W. Rajeev MicroRNAs (miRNAs) in neurodegenerative diseases Brain Pathol. 18 2008 130 138
91. T. Ohrt, D. Merkle, K. Birkenfeld, C.J. Echeverri, and P. Schwille In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5 Nucleic Acids Res. 34 2006 1369 1380
92. T.F. Outeiro, E. Kontopoulos, S.M. Altmann, I. Kufareva, K.E. Strathearn, A.M. Amore, C.B. Volk, M.M. Maxwell, J.C. Rochet, P.J. McLean, A.B. Young, R. Abagyan, M.B. Feany, B.T. Hyman, and A.G. Kazantsev Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease Science 317 2007 516 519 (Pubitemid 47196116)
93. M. Ouyang, and X. Shen Critical role of ASK1 in the 6-hydroxydopamine- induced apoptosis in human neuroblastoma SH-SY5Y cells J. Neurochem. 97 2006 234 244
94. M. Pal-Bhadra, B.A. Leibovitch, S.G. Gandhi, M. Rao, U. Bhadra, J.A. Birchler, and S.C. Elgin Heterochromatic silencing and HP1 localization in Drosophila are dependent on the RNAi machinery Science 303 2004 669 672 (Pubitemid 38141632)
95. W.M. Pardridge Intravenous, non-viral RNAi gene therapy of brain cancer Expert Opin. Biol. Ther. 4 2004 1103 1113 (Pubitemid 38937552)
96. W.M. Pardridge ShRNA and siRNA delivery to the brain Adv. Drug Deliv. Rev. 59 2007 141 152 (Pubitemid 46773051)
97. J. Parkinson An essay on the shaking palsy. 1817 J. Neuropsychiatry Clin. Neurosci. 14 1817 223 236
98. S. Patel, V. Singh, A. Kumar, Y.K. Gupta, and M.P. Singh Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration Brain Res. 1081 2006 9 18
99. S. Patt, H.J. Gertz, L. Gerhard, and J. Cervos-Navarro Pathological changes in dendrites of substantia nigra neurons in Parkinson's disease: a Golgi study Histol. Histopathol. 6 1991 373 380
100. L. Petrucelli, C. O'Farrell, P.J. Lockhart, M. Baptista, K. Kehoe, L. Vink, P. Choi, B. Wolozin, M. Farrer, J. Hardy, and M.R. Cookson Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons Neuron 36 2002 1007 1019 (Pubitemid 36044504)
101. P.N. Pushparaj, and A.J. Melendez Short interfering RNA (siRNA) as a novel therapeutic Clin. Exp. Pharmacol. Physiol. 33 2006 504 510
102. P.N. Pushparaj, J.J. Aarthi, S.D. Kumar, and J. Manikandan RNAi and RNAa - the yin and yang of RNAome Bioinformation 2 2008 235 237
103. I.A. Qureshi, and M.F. Mehler Regulation of non-coding RNA networks in the nervous system - what's the REST of the story? Neurosci. Lett. 466 2009 73 80
104. A. Reynolds, D. Leake, Q. Boese, S. Scaringe, W.S. Marshall, and A. Khvorova Rational siRNA design for RNA interference Nat. Biotechnol. 22 2004 326 330 (Pubitemid 38295766)
105. A. Reynolds, E.M. Anderson, A. Vermeulen, Y. Fedorov, K. Robinson, D. Leake, J. Karpilow, W.S. Marshall, and A. Khvorova Induction of the interferon response by siRNA is cell type- and duplex length-dependent RNA 12 2006 988 993 (Pubitemid 43788117)
106. M. Robbins, A. Judge, L. Liang, K. McClintock, E. Yaworski, and I. MacLachlan 2′-O-methyl-modified RNAs act as TLR7 antagonists Mol. Ther. 15 2007 1663 1669 (Pubitemid 47289010)
107. R. Roshan, T. Ghosh, V. Scaria, and B. Pillai MicroRNAs: novel therapeutic targets in neurodegenerative diseases Drug Discov. Today 14 2009 1123 1129
108. A. Salahpour, I.O. Medvedev, J.M. Beaulieu, R.R. Gainetdinov, and M.G. Caron Local knockdown of genes in the brain using small interfering RNA: a phenotypic comparison with knockout animals Biol. Psychiatry 61 2007 65 69 (Pubitemid 44855739)
109. P.S. Santosh, N. Arora, P. Sarma, M. Pal-Bhadra, and U. Bhadra Interaction map and selection of microRNA targets in Parkinson's disease-related genes J. Biomed. Biotechnol. 2009 2009 363145
110. S. Saxena, Z.O. Jonsson, and A. Dutta Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells J. Biol. Chem. 278 2003 44312 44319 (Pubitemid 37377177)
111. C.R. Scherzer, J.A. Grass, Z. Liao, I. Pepivani, B. Zheng, A.C. Eklund, P.A. Ney, J. Ng, M. McGoldrick, B. Mollenhauer, E.H. Bresnick, and M.G. Schlossmacher GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein Proc. Natl. Acad. Sci. USA 105 2008 10907 10912
112. G.M. Schratt, F. Tuebing, E.A. Nigh, C.G. Kane, M.E. Sabatini, M. Kiebler, and M.E. Greenberg A brain-specific microRNA regulates dendritic spine development Nature 439 2006 283 289 (Pubitemid 43128846)
113. D.S. Schwarz, G. Hutvagner, T. Du, Z. Xu, N. Aronin, and P.D. Zamore Asymmetry in the assembly of the RNAi enzyme complex Cell 115 2003 199 208 (Pubitemid 37329583)
114. M.P. Singh, S. Patel, M. Dikshit, and Y.K. Gupta Contribution of genomics and proteomics in understanding the role of modifying factors in Parkinson's disease Indian J. Biochem. Biophys. 43 2006 69 81 (Pubitemid 44475398)
115. C. Singh, I. Ahmad, and A. Kumar Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress Cell. Mol. Biol. (Noisy-le-grand) 53 2007 19 28 (Pubitemid 350164302)
116. S. Singh, K. Singh, D.K. Patel, C. Singh, C. Nath, V.K. Singh, R.K. Singh, and M.P. Singh The expression of CYP2D22, an ortholog of human CYP2D6, in mouse striatum and its modulation in 1-methyl 4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease phenotype and nicotine-mediated neuroprotection Rejuvenation Res. 12 2009 185 197
117. A.K. Singh, M.N. Tiwari, G. Upadhyay, D.K. Patel, D. Singh, O. Prakash, and M.P. Singh Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood Neurobiol. Aging 2010 10.1016/j.neurobiolagin
118. N.K. Singhal, G. Srivastava, D.K. Patel, S.K. Jain, and M.P. Singh Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse J. Pineal Res. 50 2011 97 109
119. A. Sinha, N. Srivastava, S. Singh, A.K. Singh, S. Bhushan, R. Shukla, and M.P. Singh Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach Clin. Chim. Acta 400 2009 14 20
120. M. Smeyne, J. Boyd, K.R. Shepherd, Y. Jiao, B.B. Pond, M. Hatler, R. Wolf, C. Henderson, and R.J. Smeyne GSTpi expression mediates dopaminergic neuron sensitivity in experimental Parkinsonism Proc. Natl. Acad. Sci. USA 104 2007 1977 1982 (Pubitemid 46239889)
121. G. Srivastava, K. Singh, M.N. Tiwari, and M.P. Singh Proteomics in Parkinson's disease: current trends, translational snags and future possibilities Expert Rev. Proteomics 7 2010 127 139
122. T.M. Sun, J.Z. Du, L.F. Yan, H.Q. Mao, and J. Wang Self-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA delivery Biomaterials 29 2008 4348 4355
123. R. Tabares-Seisdedos, and J.L. Rubenstein Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer Mol. Psychiatry 14 2009 563 589
124. T. Taira, Y. Saito, T. Niki, S.M. Iguchi-Ariga, K. Takahashi, and H. Ariga DJ-1 has a role in antioxidative stress to prevent cell death EMBO Rep. 5 2004 213 218 (Pubitemid 38401204)
125. G. Tang SiRNA and miRNA: an insight into RISCs Trends Biochem. Sci. 30 2005 106 114 (Pubitemid 40187303)
126. C.M. Tanner Advances in environmental epidemiology Mov. Disord. 25 2010 S58 S62
127. M.G. Tansey, M.K. McCoy, and T.C. Frank-Cannon Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention Exp. Neurol. 208 2007 1 25 (Pubitemid 47603240)
128. Y. Tomari, and P.D. Zamore Perspective: machines for RNAi Genes Dev. 19 2005 517 529 (Pubitemid 40314984)
129. M.P. van der Brug, J. Blackinton, J. Chandran, L.Y. Hao, A. Lal, K. Mazan-Mamczarz, J. Martindale, C. Xie, R. Ahmad, K.J. Thomas, A. Beilina, J.R. Gibbs, J. Ding, A.J. Myers, M. Zhan, H. Cai, N.M. Bonini, M. Gorospe, and M.R. Cookson RNA binding activity of the recessive Parkinsonism protein DJ-1 supports involvement in multiple cellular pathways Proc. Natl. Acad. Sci. USA 105 2008 10244 10249
130. R. Ved, S. Saha, B. Westlund, C. Perier, L. Burnam, A. Sluder, M. Hoener, C.M. Rodrigues, A. Alfonso, C. Steer, L. Liu, S. Przedborski, and B. Wolozin Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans J. Biol. Chem. 280 2005 42655 42668 (Pubitemid 43049224)
131. G. Wang, J.M. van der Walt, G. Mayhew, Y.J. Li, S. Züchner, W.K. Scott, E.R. Martin, and J.M. Vance Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein Am. J. Hum. Genet. 82 2008 283 289
132. J. Wang, H. Lou, C.J. Pedersen, A.D. Smith, and R.G. Perez 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria J. Biol. Chem. 284 2009 14011 14019
133. T. Watanabe, Y. Totoki, A. Toyoda, M. Kaneda, S. Kuramochi-Miyagawa, Y. Obata, H. Chiba, Y. Kohara, T. Kono, T. Nakano, M.A. Surani, Y. Sakaki, and H. Sasaki Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes Nature 453 2008 539 543 (Pubitemid 351733315)
134. J.K. Watts, N. Choubdar, K. Sadalapure, F. Robert, A.S. Wahba, J. Pelletier, B.M. Pinto, and M.J. Damha 2′-Fluoro-4′-thioarabino- modified oligonucleotides: conformational switches linked to siRNA activity Nucleic Acids Res. 35 2007 1441 1451 (Pubitemid 46592867)
135. A. Wood-Kaczmar, S. Gandhi, Z. Yao, A.Y. Abramov, E.A. Miljan, G. Keen, L. Stanyer, I. Hargreaves, K. Klupsch, E. Deas, J. Downward, L. Mansfield, P. Jat, J. Taylor, S. Heales, M.R. Duchen, D. Latchman, S.J. Tabrizi, and N.W. Wood PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons PLoS One 3 2008 e2455
136. L. Wu, and J.G. Belasco Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells Mol. Cell. Biol. 25 2005 9198 9208 (Pubitemid 41507823)
137. J. Xie, Q. Xie, H. Zhang, S.L. Ameres, J.H. Hung, Q. Su, R. He, X. Mu, S. Seher Ahmed, S. Park, H. Kato, C. Li, C. Mueller, C.C. Mello, Z. Weng, T.R. Flotte, P.D. Zamore, and G. Gao MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression Mol. Ther. 19 2011 526 535
138. Y. Yang, I. Nishimura, Y. Imai, R. Takahashi, and B. Lu Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila Neuron 37 2003 911 924 (Pubitemid 36398298)
139. Y. Yang, S. Gehrke, M.E. Haque, Y. Imai, J. Kosek, L. Yang, M.F. Beal, I. Nishimura, K. Wakamatsu, S. Ito, R. Takahashi, and B. Lu Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling Proc. Natl. Acad. Sci. USA 102 2005 13670 13675 (Pubitemid 41420906)
140. J.W. Yoo, S.W. Hong, S. Kim, and D.K. Lee Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific Biochem. Biophys. Res. Commun. 347 2006 1053 1058 (Pubitemid 44118221)
141. A. Zaheer, S. Zaheer, S.K. Sahu, S. Knight, H. Khosravi, S.N. Mathur, and R. Lim A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines J. Neurochem. 101 2007 364 376 (Pubitemid 46525279)
142. Y. Zeng, R. Yi, and B.R. Cullen MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms Proc. Natl. Acad. Sci. USA 100 2003 9779 9784 (Pubitemid 37087018)
143. D. Zhang, V. Anantharam, A. Kanthasamy, and A.G. Kanthasamy Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease J. Pharmacol. Exp. Ther. 322 2007 913 922 (Pubitemid 47295809)
144. N. Zhong, C.Y. Kim, P. Rizzu, C. Geula, D.R. Porter, E.N. Pothos, F. Squitieri, P. Heutink, and J. Xu DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor J. Biol. Chem. 281 2006 20940 20948 (Pubitemid 44115435)
145. C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E.A. Schon, and S. Przedborski The kinase domain of mitochondrial PINK1 faces the cytoplasm Proc. Natl. Acad. Sci. USA 105 2008 12022 12027
146. E. Ziviani, R.N. Tao, and A.J. Whitworth Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin Proc. Natl. Acad. Sci. USA 107 2010 5018 5023